文献速递前列腺癌

预测前列腺癌挽救性局灶消融失败风险模型的外部验证

External validation of a risk model predicting failure of salvage focal ablation for prostate cancer.
PubMed 文献 · BJU Int · 2023-06-29

本研究利用前瞻性英国多中心数据(FORECAST试验及HEAT、ICE注册库,共168例),外部验证一个预测局部放疗后复发前列腺癌患者挽救性局灶消融2年内失败的风险模型。模型区分度中等(C指数0.65),校准良好(校准斜率1.01),在风险阈值≥0.23时较「全部治疗」策略有增量净获益。结论认为该模型可用于改善患者选择,但需更大规模、更长随访的国际队列进一步验证。

要点

  • 模型在168例患者中外部验证,2年内失败72/168(43%),C指数0.65(95%CI 0.58-0.71)。
  • 校准斜率1.01,预测失败与实际观察失败高度一致。
  • 决策曲线分析显示风险阈值≥0.23时净获益优于「全部治疗」策略。

核心结论

  • 该模型外部验证显示区分度中等但校准良好且具有临床效用,可用于预测挽救性局灶消融2年内失败。
  • 作者认为该模型可合理用于改善挽救性局灶消融合适候选者的选择,在与患者讨论挽救方案时应考虑使用。
  • 作者建议在更大规模、更长随访的国际队列中进一步验证。

研究设计与样本

  • 前瞻性、英国多中心外部验证研究,数据来自FORECAST试验(NCT01883128;2014-2018年;6个中心)及HEAT和ICE英国注册库(2006-2022年;9个中心)。
  • 纳入活检确诊的≤T3bN0M0、既往接受外照射放疗或近距离放疗后复发的局限性前列腺癌患者,共168例。
  • 患者接受挽救性局灶HIFU或冷冻治疗,选择主要基于解剖因素。
  • 按原多变量Cox回归模型预测复合失败结局,于挽救治疗后2年评估区分度(C指数)、校准(校准曲线及斜率)和决策曲线分析。

主要发现

  • 全部随访期间84/168(50%)发生主要结局,2年内72/168(43%)发生主要结局。
  • C指数为0.65(95%CI 0.58-0.71)。
  • 图形检查显示预测失败与观察失败高度一致,校准斜率为1.01。
  • 决策曲线分析中,在风险阈值≥0.23时较「全部治疗」策略有增量净获益,在0.14-0.52风险阈值范围的大部分及0.26-0.36范围的全部净获益更高。

关键数值与推荐

  • 模型区分度C指数0.65(95%CI 0.58-0.71)。
  • 校准斜率1.01。
  • 决策曲线分析风险阈值0.14-0.52和0.26-0.36分别对应既往发表的挽救性局部治疗2年无复发生存率的合并值。
  • 风险阈值≥0.23时较「全部治疗」策略有增量净获益。

临床怎么用

  • 作者认为该模型可合理用于改善挽救性局灶消融合适候选者的选择。
  • 作者建议在与患者讨论挽救方案时应考虑使用该模型。
  • 作者建议在更大规模、更长随访的国际队列中进一步验证。

局限性

  • 作者建议需在更大规模、更长随访的国际队列中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To externally validate a published model predicting failure within 2 years after salvage focal ablation in men with localised radiorecurrent prostate cancer using a prospective, UK multicentre dataset. PATIENTS AND METHODS: Patients with biopsy-confirmed ≤T3bN0M0 cancer after previous external beam radiotherapy or brachytherapy were included from the FOcal RECurrent Assessment and Salvage Treatment (FORECAST) trial (NCT01883128; 2014-2018; six centres), and from the high-intensity focussed ultrasound (HIFU) Evaluation and Assessment of Treatment (HEAT) and International Cryotherapy Evaluation (ICE) UK-based registries (2006-2022; nine centres). Eligible patients underwent either salvage focal HIFU or cryotherapy, with the choice based predominantly on anatomical factors. Per the original multivariable Cox regression model, the predicted outcome was a composite failure outcome. Model performance was assessed at 2 years post-salvage with discrimination (concordance index [C-index]), calibration (calibration curve and slope), and decision curve analysis. For the latter, two clinically-reasonable risk threshold ranges of 0.14-0.52 and 0.26-0.36 were considered, corresponding to previously published pooled 2-year recurrence-free survival rates for salvage local treatments. RESULTS: A total of 168 patients were included, of whom 84/168 (50%) experienced the primary outcome in all follow-ups, and 72/168 (43%) within 2 years. The C-index was 0.65 (95% confidence interval 0.58-0.71). On graphical inspection, there was close agreement between predicted and observed failure. The calibration slope was 1.01. In decision curve analysis, there was incremental net benefit vs a 'treat all' strategy at risk thresholds of ≥0.23. The net benefit was therefore higher across the majority of the 0.14-0.52 risk threshold range, and all of the 0.26-0.36 range. CONCLUSION: In external validation using prospective, multicentre data, this model demonstrated modest discrimination but good calibration and clinical utility for predicting failure of salvage focal ablation within 2 years. This model could be reasonably used to improve selection of appropriate treatment candidates for salvage focal ablation, and its use should be considered when discussing salvage options with patients. Further validation in larger, international cohorts with longer follow-up is recommended.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Light A, Peters M, Reddy D, et al. External validation of a risk model predicting failure of salvage focal ablation for prostate cancer. BJU Int. 2023. PMID: 37385981. doi:10.1111/bju.16102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。